期刊文献+

程序性坏死在铝致神经母细胞瘤细胞SH-SY5Y死亡中的作用 被引量:4

Role of necroptosis in aluminum induced SH-SY5Y cell death
原文传递
导出
摘要 目的探讨程序性坏死是否存在于铝诱导的神经母细胞瘤细胞SH—SY5Y的死亡途径中。方法培养SH—SY5Y细胞,并用4mmol/L AlCl3·6H2O染毒制作铝致神经细胞死亡模型,按加入Nec-1剂量不同分别设对照组(0μmol/L)和30、60、90μmol/L组,检测SH-SY5Y细胞的活力、线粒体膜电位、活性氧含量及细胞的凋亡率和坏死率等。结果研究表明,加入Nec-1可以显著改善染铝后的细胞坏死样形态学改变。流式细胞仪检测结果表明,加入不同剂量的Nec-1(30、60、90μmol/L)后其细胞活力分别为0.58±0.03、0.68±0.04、1.03±0.17,与对照组(0.28±0.05)相比,差异有统计学意义(t值分别为3.25、3.36、4.56,P值均〈0.05)。Annexin V—PI双染法测定结果显示,不同剂量Nec-1(30、60、90μmol/L)作用后坏死率分别为10.40%±0.64%、5.43%±0.68%、6.28%±0.35%,与对照组(16.46%±0.54%)相比,差异有统计学意义(t值分别为3.62、7.32、6.96,P值均〈0.05),可以明显降低SH-SY5Y细胞的坏死率,但其作用后SH—SY5Y细胞凋亡率分别为7.66%±0.53%、5.68%±0.41%、4.13%±0.41%,与对照组(8.68%±0.36%)相比,差异无统计学意义(F=6.33,P=0.11)。加入不同剂量Nec-1(30、60、90μmol/L)后,其线粒体膜电位分别为49.42±5.96、84.79±6.86、95.51±7.01,60、90μmol/L剂量组与对照组(67.54±6.36)相比,差异有统计学意义(t值分别为3.21、4.01,P值均〈0.05)。但加入不同剂量的Nec-1(30、60、90μmol/L)后其活性氧含量分别为52.79±2.36、54.68±1.91、59.23±2.96,对照组为54.07±3.32,各组间差异无统计学意义(F=5.26,P=0.19)。结论用程序性坏死的特异阻断剂Nec-1可以有效阻断铝致SH—SY5Y细胞的死亡通路,提示程序性坏死是导致铝神经毒性的原因之一。程序性坏死在铝致SH—SY5Y细胞的死亡中发挥了重要作用。 Objective To study whether necroptosis exists or not in neural cell death induced by aluminum. Methods SH-SY5Y cells were treated with 4 mmol/L AlCl3 · 6H2O. The cell viability was determined with CCK-8 kit after treated with Nec-1 at different dosages (0, 30, 60, 90 μmol/L ). Mitochondria membrane potential ( MMP ), content of reactive oxygen species ( ROS ), and apoptotic rate/ necrotic rates were measured with cytometry. Results Nec-1 ameliorated the necrotic-like cell morphology, the cell viability were 0. 28 ± 0. 05,0. 58 ± 0. 03,0. 68 ± 0. 04, and 1.03 ± 0. 17, there were significant differences between the Nec-1 treated groups and that of controls ( t values were 3.25,3.36,4. 56 ; P 〈 0. 05). After Nec-1 treatment, the necrotic rates were 16.46% ± 0. 54%, 10. 40% ± 0. 64%, 5.43% ± 0. 68% ,and 6. 28% ±0. 35% ,there were significant differences between the Nee-1 treated cells and that of controls( t values were 3.62,7.32,6. 96;P 〈 0. 05 ); while the apoptotic rates were 8. 68 ± 0. 36,7. 66 ± 0. 53,5.68 ± 0. 41, and 4. 13 ± 0. 41, there was no significant difference among the groups ( F = 6. 33, P = 0. 11 ). Cytometry had shown the increased cell MMPs after Nee-1 treatment, which were 67. 54 ± 6. 36, 49.42 ±5.96,84.79±6. 86,and 95.51 ±7.01 ,there were significant differences as comparing MMPs of the middle and high dosage of Nec-1 treated cells with those of controls(t values were 3.21,4. 01 ; P 〈0. 05) ; while ROS contents in the Nec-1 treated SH-SYSY ceils were 54. 07 ± 3.32,52.79 ± 2. 36,54.68 ± 1.91, and 59. 23 ± 2.96, there was no significant difference among the groups ( F = 5.26, P = 0. 19). Conclusion Nec-1 ,as a specific inhibitor of necroptosis, might effectively block the cell death pathway induced by aluminum,it indicates that necroptosis should be one of the major causes of the SH-SYSY cell toxicity induced by aluminum, and necroptosis also plays an important role in aluminum induced SH-SYSY cell death.
出处 《中华预防医学杂志》 CAS CSCD 北大核心 2009年第2期132-136,共5页 Chinese Journal of Preventive Medicine
基金 国家自然科学基金(30671777,30740032) 教育部博士点基金(20050114001)
关键词 细胞死亡 程序性坏死 神经母细胞瘤 Cell death Aluminum Necroptosis Neuroblastoma
  • 相关文献

参考文献15

  • 1Abraham MC, Shaham S. Death without caspases, caspases without death(Review). Trends Cell Biol,2004,14 : 184-193.
  • 2Castejon OJ, Arismendi GJ. Nerve cell death types in the edematous human cerebral cortex. J Submicrosc Cytol Pathol, 2006,38 : 21-36.
  • 3Wei L,Ying DJ,Cui L,et al. Necrosis,apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats. Brain Res ,2004,1022 ( 1/2 ) : 54-61.
  • 4Degterev A, Huang Z, Boyee M. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol, 2005,1 : 112-119.
  • 5Teng X, Degterev A, Jagtap P, et al. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett,2005, 15 : 5039-5044.
  • 6Kawahara M. Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases (Review). J Alzheimers Dis ,2005,8 : 171-182.
  • 7Perl DP, Moalem S. Aluminum and Alzheimer's disease, a personal perspective after 25 years(Review). J Alzheimers Dis, 2006,9 ( 3 Suppl) :291-300.
  • 8Gupta VB, Anitha S, Hegde ML, et al. Aluminium in Alzheimer's disease: are we still at a crossroad(Review) ? Cell Mol Life Sci, 2005,62 : 143-158.
  • 9Zilkova M, Koson P, Zilka N. The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease(Review). Bratisl Lek Listy,2006,107 (9/10) :366-373.
  • 10Smith CC, Davidson SM, Lim SY, et al. Necrostatin : a potentially novel cardioprotective agent? Cardiovasc Drugs Ther, 2007,21 : 227-233.

同被引文献57

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部